(19)
(11) EP 3 923 923 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
03.07.2024 Bulletin 2024/27

(45) Mention of the grant of the patent:
05.06.2024 Bulletin 2024/23

(21) Application number: 19714781.2

(22) Date of filing: 13.02.2019
(51) International Patent Classification (IPC): 
A61K 31/185(2006.01)
A61P 1/02(2006.01)
A61P 31/00(2006.01)
A61K 47/00(2006.01)
A61K 9/08(2006.01)
 A61K 45/06(2006.01)
A61P 17/02(2006.01)
A61P 31/04(2006.01)
A61K 9/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/185; A61P 17/02; A61P 31/00; A61P 31/04; A61P 1/02; A61K 9/006; A61K 9/0063; A61K 9/06; A61K 9/08; A61K 47/10; A61K 45/06
(86) International application number:
PCT/IB2019/051146
(87) International publication number:
WO 2020/165628 (20.08.2020 Gazette 2020/34)

(54)

COMPOSITIONS FOR REMOVING NECROTIC OR INFECTED TISSUES FROM BODY SURFACE LESIONS AND FROM ORAL CAVITY

ZUSAMMENSETZUNGEN ZUR ENTFERNUNG VON NEKROTISCHEN ODER INFIZIERTEN GEWEBEN AUS KÖRPEROBERFLÄCHENLÄSIONEN UND AUS DER MUNDHÖHLE

COMPOSITIONS POUR ÉLIMINER DES TISSUS NÉCROTIQUES OU INFECTÉS DE LÉSIONS DE SURFACE CORPORELLE ET DE CAVITÉ BUCCALE

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(43) Date of publication of application:
22.12.2021 Bulletin 2021/51

(60) Divisional application:
24172485.5 / 4385496

(73) Proprietor: DEBx Medical Holding B.V.
1083 HN Amsterdam (NL)

(72) Inventors:
  • BIGNOZZI, Carlo Alberto
    44124 Ferrara (IT)
  • COGO, Alberto
    36100 Vicenza (IT)
  • CARINCI, Francesco
    40124 Bologna (IT)

(74) Representative: Nederlandsch Octrooibureau 
P.O. Box 29720
2502 LS The Hague
2502 LS The Hague (NL)


(56) References cited: : 
US-A1- 2016 058 718
   
  • Anonymous: "Methanesulfonic acid - National Library of Medicine HSDB Database", , 23 October 2019 (2019-10-23), XP055635439, Retrieved from the Internet: URL:https://toxnet.nlm.nih.gov/cgi-bin/sis /search/a?dbs+hsdb:@term+@DOCNO+5004 [retrieved on 2019-10-23]
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).